![](/img/cover-not-exists.png)
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results
Markus Dietlein, Kerstin Weber, Afschin Gandjour, Detlef Moka, Peter Theissen, Karl W. Lauterbach, Harald SchichaVolume:
27
Language:
english
Pages:
12
DOI:
10.1007/s002590000376
Date:
November, 2000
File:
PDF, 150 KB
english, 2000